ENTX

Entera Bio Ltd. - Ordinary Shares (ENTX)

About Entera Bio Ltd. - Ordinary Shares (ENTX)

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

Details

Daily high

$3.10

Daily low

$2.90

Price at open

$3.07

52 Week High

$4.20

52 Week Low

$0.91

Market cap

540.9M

Dividend yield

Volume

219,763

Avg. volume

554,835

P/E ratio

-8.85

Entera Bio Ltd. - Ordinary Shares News